DR Reddys director files initial ownership report

DR REDDYS LABORATORIES LTD director files initial ownership report Penny Chan Wan, a director of DR REDDYS LABORATORIES LTD, filed an initial Form 3 reporting beneficial ownership in the company’s securities.

Accepted by SEC EDGAR 03/27/2026 - 08:39 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director files initial ownership report

Penny Chan Wan, a director of DR REDDYS LABORATORIES LTD, filed an initial Form 3 reporting beneficial ownership in the company’s securities. The summary data in this filing shows no reported transactions or derivative positions and no separate holding entries at this time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DR REDDYS LABORATORIES (RDY) Form 3 for Penny Chan Wan show?

The Form 3 shows that director Penny Chan Wan has filed an initial statement of beneficial ownership in DR REDDYS LABORATORIES LTD. The summary indicates no reported transactions, holdings, or derivative positions in this filing.

Are there any buy or sell transactions in the RDY Form 3 for Penny Chan Wan?

No. The transaction summary for Penny Chan Wan lists buyCount, sellCount, acquireCount, and disposeCount all as zero. This means the Form 3 does not report any purchases, sales, or other transactions in DR REDDYS LABORATORIES LTD securities.

Does the DR REDDYS LABORATORIES (RDY) Form 3 disclose derivative securities for Penny Chan Wan?

No. The filing’s derivativeSummary is empty and derivativeTransactionCount is zero. This indicates that no options, warrants, or other derivative securities related to DR REDDYS LABORATORIES LTD are reported for Penny Chan Wan in this Form 3.

What insider role does Penny Chan Wan have at DR REDDYS LABORATORIES (RDY)?

According to the Form 3, Penny Chan Wan is identified as a director of DR REDDYS LABORATORIES LTD. The filing confirms director status, while indicating no officer role, no ten percent owner status, and no officer title information.

Does the RDY Form 3 for Penny Chan Wan show any net buying or selling activity?

No. The transactionSummary shows netBuySellShares as zero and netBuySellDirection as neutral. This reflects the absence of any reported buying, selling, or other transaction activity in DR REDDYS LABORATORIES LTD securities in this Form 3.

Are there any reported gifts or tax withholdings in the RDY Form 3 for Penny Chan Wan?

No. The Form 3 lists giftCount and taxWithholdingCount as zero for Penny Chan Wan. This means there are no reported gifts of DR REDDYS LABORATORIES LTD shares and no shares withheld for taxes in this initial ownership statement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

WAN PENNY CHAN

(Last) (First) (Middle)

1774, INDIAN RUN ROAD

MALVERN

(Street)

PA 19355-9715 PENNSYLVANIA 019355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ PENNY CHAN WAN	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)